Slides Airfinity – 5th GLOBAL BIOPHARMA CEO / TOP EXECS VIRTUAL PRESS BRIEFING – COVID-19 (8 December 2020)


On 21 October 2025 in Nadi, Fiji, IFPMA delivered a statement at the 76th Session of the WHO Regional Committee for the Western Pacific on “Implementing the International Health Regulations (2005) amendments.” We commend the Western Pacific Region for its engagement to develop priority actions for countries and areas in the region to utilize the...
Read moreOn 14 October 2025 in Colombo, Sri Lanka, IFPMA delivered a statement on primary health care (PHC) and universal health coverage (UHC) at the 78th Session of the WHO Regional Committee for South-East Asia. IFPMA welcomes the agenda items on PHC and UHC. Unlocking investment in primary care is critical if we are to build...
Read moreOn 1 October 2025 in Washington, D.C., IFPMA and FIFARMA delivered a statement on Agenda Item 4.5 Plan of Action on Noncommunicable Disease Prevention and Control 2025–2030 during the 77th Session of the Regional Committee of WHO for the Americas. The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and the Latin American Federation of...
Read more